Related Experiment Videos
[Lipid status in the physician's laboratory]
1Landeskrankenhaus Feldkirch.
Insights
Tailor lipid analysis to individual risk for hyperlipidemia and atherosclerosis. Recommendations range from basic cholesterol and HDL checks in healthy individuals to comprehensive profiles including triglycerides and apolipoproteins for high-risk patients.
Area of Science:
- Clinical Biochemistry
- Cardiovascular Medicine
- Diagnostic Laboratory Medicine
Context:
- Hyperlipidemia and atherosclerosis risk stratification necessitates tailored lipid analysis.
- Guidelines vary based on family history, existing atherosclerotic disease, diabetes mellitus, and pancreatitis.
- Accurate lipid profiling is crucial for effective disease management and prevention.
Purpose:
- To outline a risk-stratified approach to lipid analysis.
- To define appropriate lipid testing panels based on clinical presentation and patient history.
- To guide clinicians in selecting the most relevant lipid markers for diagnosing and managing dyslipidemias and related conditions.
Summary:
- For healthy individuals without a family history, total cholesterol and HDL cholesterol are sufficient.
- Patients with a family history of hyperlipidemia require triglyceride measurement in addition.
- Those with atherosclerotic disease or diabetes mellitus need a full lipid profile (cholesterol, triglycerides, HDL), with apolipoprotein (a) or B considered for complex cases.
- Pancreatitis patients benefit from longitudinal triglyceride and HDL triglyceride assessment to identify underlying hyperlipidemia.
Impact:
- Optimized lipid testing reduces unnecessary investigations and healthcare costs.
- Personalized diagnostic strategies improve the accuracy of hyperlipidemia and atherosclerosis detection.
- Enhanced lipid analysis supports timely and effective therapeutic interventions, potentially reducing cardiovascular events.
Abstract:
Lipid analysis should be tailored to the likelihood of hyperlipidemia and atherosclerosis. In healthy individuals without a family history of hyperlipidemia, it is sufficient to obtain readings of total cholesterol and high-density lipoprotein (HDL) cholesterol. In patients with a family history of hyperlipidemia, in addition, triglycerides should be measured. In patients with manifest atherosclerotic disease, the lipid profile should always include plasma cholesterol and triglycerides as well as HDL cholesterol; if these do not explain presence or extent of atherosclerosis, apolipoprotein (a) should be measured. Patients with diabetes mellitus should undergo the same diagnostic work-up as those with atherosclerotic disease. An apolipoprotein B reading (together with triglyceride levels) is sometimes helpful in patients with diabetes mellitus, allowing to estimate the size of triglyceride-rich lipoproteins. In patients with pancreatitis, longitudinal assessment of plasma triglycerides and, if available, measurement of HDL triglyceride are useful to unmask underlying hyperlipidemia.